Now that ftt is fully funded for the current trial is it time...

Now that ftt is fully funded for the current trial is it time for it to go for a run?

Results are getting nearer and success is expected (although never guaranteed).

I'm a biotech investor, and the sector hasn't looked so go for ages, following successful deals and trials.

ftt has a large market, and it's one that could save health authorities heaps, let alone benefit patients - so it'll certainly be attractive.

I suggest buy at 4c and get set for the results.

all imho.

Cheers